by The global medical device contract manufacturing market is projected to reach USD 253.86B by 2034, growing at a CAGR of 10.89% from USD 90.29B in 2024.
Medical Device Contract Manufacturing Market Key Takeaways
- North America holds the largest market share at 41% in 2024.
- The IVD devices segment leads the market by device type in 2024.
- The device development and manufacturing services segment generated over 54% of revenue share in 2024.
- The orthopedic segment held the largest market share by application in 2024.
- The orthopedic segment is expected to grow at a CAGR of 12.9% during the forecast period.
The Medical Device Contract Manufacturing Market involves outsourcing the production of medical devices to third-party manufacturers. It includes various services such as product design, development, and assembly for companies in the medical device industry. This market is growing rapidly, driven by factors like increasing demand for advanced medical devices, cost-effective production, and regulatory compliance. North America holds the largest share, while segments like in-vitro diagnostic (IVD) devices and orthopedic applications are showing significant growth. The market is also witnessing increased investments in R&D and technological innovations. By 2034, it is projected to reach USD 253.86 billion, with a compound annual growth rate (CAGR) of 10.89%.
Sample Link: https://www.precedenceresearch.com/sample/1051
Key Drivers
Opportunities
- Growing demand for personalized medicine: Custom manufacturing solutions for specific patient needs create new market opportunities.
- Technological advancements: Integration of automation and AI in manufacturing processes can enhance efficiency and quality.
- Expanding healthcare markets: Emerging economies provide untapped potential for medical device manufacturers.
- Increasing outsourcing trends: Companies are increasingly outsourcing production to focus on core competencies and reduce costs.
- Rising prevalence of chronic diseases: A growing need for medical devices to treat long-term conditions offers significant market potential.
Challenges
- Stringent regulatory requirements: Compliance with complex regulations can increase production timelines and costs.
- Intellectual property concerns: Protecting proprietary technologies and designs when outsourcing manufacturing can be difficult.
- Supply chain disruptions: Global supply chain challenges may affect raw material availability and manufacturing timelines.
- High competition: The presence of numerous contract manufacturers intensifies competition, making it challenging to differentiate.
- Quality control risks: Ensuring consistent product quality across different manufacturing facilities and regions remains a major challenge.
Regional Insights
The Medical Device Contract Manufacturing Market is led by North America, which accounts for the largest share due to its well-established healthcare infrastructure, high demand for advanced medical devices, and strong presence of key players. The region also benefits from favorable regulatory environments and significant investment in research and development. Europe holds a substantial market share as well, driven by increasing healthcare spending, a growing aging population, and the presence of leading medical device manufacturers. The Asia Pacific region is expected to witness the fastest growth, particularly in countries like China and India, due to lower manufacturing costs, expanding healthcare systems, and rising medical device demand. Latin America and the Middle East & Africa are emerging markets, with moderate growth driven by healthcare improvements and increased outsourcing of manufacturing services.
Don’t Miss Out: Solid Tumor Cancer Treatment Market
Market Key Players
- SMC Ltd.
- Phillips-Medisize Corporation
- Benchmark Electronics Inc.
- Integer Holdings Corporation
- Gerresheimer AG
- Consort Medical PLC
- Tessy Plastics Corp
- Tecomet, Inc.
Recent News
Recently, EQT, a Swedish private equity firm, is exploring the acquisition of Device Technologies, a medical technology service provider, with the auction expected to exceed $1 billion. The global medical device contract manufacturing market, valued at $71.1 billion in 2023, is projected to grow at a CAGR of 11.4%, reaching approximately $149.4 billion by 2029. Novo Nordisk has invested $11 billion in new manufacturing sites to meet the increasing demand for GLP-1 drugs. Meanwhile, CVC Capital Partners is seeking a buyer for its majority stake in Genetic Group, valued at €700 million. Omega Diagnostics has settled a dispute with the UK government, refocusing on its health and nutrition business. Additionally, Ypsomed has secured a contract with Novo Nordisk for injection pens, and Cardinal Health plans to close its medical device plant in Offaly, Ireland, resulting in the loss of over 300 jobs.
Market Segmentation
By Device Type
- IVD Devices
- Drug Delivery Devices
- Diagnostic Imaging Devices
- Patient Monitoring Devices
- Therapeutic Patient Assistive Devices
- Minimally Access Surgical Instruments
- Others
By Service
- Device Development and Manufacturing Services
- Quality Management Services
- Final Goods Assembly Services
By Application
- Laparoscopy
- Pulmonary
- Urology & Gynecology
- Cardiovascular
- Orthopedic
- Oncology
- Neurovascular
- Radiology
- Others
